FIT EASY Inc. (212A.T)
Gifu, JP
FIT EASY, Inc engages in store and service development utilizing know-how as an amusement fitness club. It provides management and operation of an amusement fitness club, planning of amusement fitness club expansion of franchise business. Fit easy products include fit aero, fit golf, fit sauna, fit lounge, self-essence, fit race, fit baseball, tanning machine, 02 room2, bouldering wall and fit ride. The company was founded by Kunie Senji, Hiroki Morita and Norihisa Kunie on July 02, 2018 and is headquartered in Gifu, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.36% | -0.84% | -6.67% | -12.65% | -11.52% | -14.73% | +29.59% | +100.80% | +100.80% | +100.80% | +100.80% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Personal Products & Services: +6.6%+45.8% ★
-
EPS growth Personal Products & Services: +19.6%+35.4% ★
-
FCF margin FCF growth · Personal Products & Services: +11.7%+8.9% Q4'25: +11.1%
-
EBIT margin Personal Products & Services: +10.5%+23.8% ★ Q4'25: +23.1%
-
ROIC Personal Products & Services: +6.9%+49.0% ★ Q4'25: +120.0%
-
Share dilution Personal Products & Services: +0.0%+4.4%
-
Debt / EBITDA Net debt/EBITDA · Personal Products & Services: 0.59×0.20× ★ Q4'25: 0.09×
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Oct 2024 actual |
Oct 2025 actual |
Oct 2026 2 Rev. Ana. 2 EPS Ana. |
Oct 2027 2 Rev. Ana. 2 EPS Ana. |
Oct 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
6.67B
est: 6.06B (+10.1%)
|
9.73B
est: 9.20B (+5.8%)
|
13.62B
13.62B – 13.62B
+48.0% YoY
|
18.00B
18.00B – 18.00B
+32.2% YoY
|
24.00B
24.00B – 24.00B
+33.3% YoY
|
| EBITDA |
1.83B
est: 1.59B (+15.1%)
|
2.53B
est: 2.41B (+4.8%)
|
3.57B
3.57B – 3.57B
+48.0% YoY
|
4.72B
4.72B – 4.72B
+32.2% YoY
|
6.29B
6.29B – 6.29B
+33.3% YoY
|
| EBIT |
1.63B
est: 1.33B (+22.8%)
|
2.31B
est: 2.02B (+14.7%)
|
2.98B
2.98B – 2.98B
+48.0% YoY
|
3.94B
3.94B – 3.94B
+32.2% YoY
|
5.26B
5.26B – 5.26B
+33.3% YoY
|
| Net Income |
1.08B
est: 1.00B (+7.9%)
|
1.53B
est: 1.53B (+0.2%)
|
2.13B
2.13B – 2.13B
+39.7% YoY
|
2.81B
2.81B – 2.81B
+31.7% YoY
|
3.77B
3.77B – 3.77B
+34.3% YoY
|
| SGA |
684.36M
est: 608.10M (+12.5%)
|
1.11B
est: 922.57M (+20.5%)
|
1.37B
1.37B – 1.37B
+48.0% YoY
|
1.81B
1.81B – 1.81B
+32.2% YoY
|
2.41B
2.41B – 2.41B
+33.3% YoY
|
| EPS |
71.24
est: 61.20 (+16.4%)
|
96.11
est: 93.10 (+3.2%)
|
130.10
130.10 – 130.10
+39.7% YoY
|
171.30
171.30 – 171.30
+31.7% YoY
|
230.00
230.00 – 230.00
+34.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-28 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-27 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-26 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-25 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-15 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-01 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-15 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-14 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hiroyuki Morita | MD, Head of Sales Division & Director | — | — |
| Norihisa Kunie | Director & Head of Corporate Planning Headquarters | — | — |
| Senji Kunie | President & Representative Director | — | male |
| Yuji Fujiwara | MD, Head of Business Management Department & Director | — | — |
| Yuki Nakamori | COO, VP & Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 212A.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
